Christopher Ogden

Companies

• CytomX Therapeutics, Inc.Chief financial officer Jun 14, 2024 to now¹
• CytomX Therapeutics, Inc.Officer Mar 9, 2022 to Mar 21, 2024²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• CTCytomX Therapeutics, Inc. CTMX295,324 shares³$673.3K at $2.28Jun 15, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 15, 2026Sold 1,624 shares at $3.05 of CytomX Therapeutics, Inc.³
• Mar 17, 2026Sold 19,323 shares at $6.42 of CytomX Therapeutics, Inc.⁴
• Feb 2, 2026Granted 90,000 shares of CytomX Therapeutics, Inc.⁵
• Jun 16, 2025Sold 10,614 shares at $2.69 of CytomX Therapeutics, Inc.⁶
• Jun 13, 2025Exercised options 37,500 shares of CytomX Therapeutics, Inc.⁶
• Jun 13, 2025Sold 1,641 shares at $2.95 of CytomX Therapeutics, Inc.⁶
• Mar 18, 2025Sold 8,551 shares at $0.60 of CytomX Therapeutics, Inc.⁷
• Feb 4, 2025Granted 57,500 shares of CytomX Therapeutics, Inc.⁸
• Feb 4, 2025Granted 44,000 shares of CytomX Therapeutics, Inc.⁸
• Aug 20, 2024Sold 1,984 shares at $1.23 of CytomX Therapeutics, Inc.⁹
• Aug 20, 2024Exercised options 6,875 shares of CytomX Therapeutics, Inc.⁹
• Jun 12, 2024Granted 17,500 shares of CytomX Therapeutics, Inc.¹⁰
• Mar 19, 2024Sold 2,971 shares at $2.09 of CytomX Therapeutics, Inc.¹¹
• Jan 18, 2024Granted 40,000 shares of CytomX Therapeutics, Inc.¹²
• Dec 20, 2023Sold 1,990 shares at $1.38 of CytomX Therapeutics, Inc.¹³
• Dec 17, 2023Exercised options 6,875 shares of CytomX Therapeutics, Inc.¹⁴
• Mar 16, 2023Sold 516 shares at $1.98 of CytomX Therapeutics, Inc.¹⁵
• Feb 2, 2023Granted 25,000 shares of CytomX Therapeutics, Inc.¹⁶